Trial Design 1 article

Trial Design concerns the architecture of a clinical study before results are known: randomization, controls, blinding, eligibility, dose escalation, sample size and adaptive features determine what questions the study can answer. Endpoint choice appears here as part of protocol construction, while Clinical Endpoints examines the measures themselves in greater depth. The section is about design logic and tradeoffs, not statistical interpretation of completed results or operational execution alone.